Business Wire

Baxter Obtains U.S. FDA Emergency Use Authorization for Regiocit Replacement Solution Used in CRRT

Baxter has received EUAs for several of its products used in CRRT, including Oxiris, the HF20 Set and the ST Set. Oxiris is the only filter set available in the U.S. to reduce pro-inflammatory ...
Business Wire

Baxter Launches PrisMax 2 System to Advance Critical Care Delivery for Patients and Hospitals

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global leader in acute care, today announced the global launch of PrisMax 2, the latest version of the company’s ...
Nasdaq

Baxter's (BAX) PrisMax 2 to Simplify Organ Support Therapies

Baxter International Inc. BAX recently announced the global launch of the latest version of its next-generation platform, PrisMax 2. The PrisMax 2 system aims to help streamline the delivery of ...
Nasdaq

Baxter Obtains U.S. FDA Emergency Use Authorization for Regiocit Replacement Solution Used in CRRT

Only authorized citrate-based replacement solution available in the U.S. for use in continuous renal replacement therapy (CRRT) during COVID-19 pandemic Supports need for regional citrate ...